Cancer-targeting carrier dyes
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
14
NCT04970992
A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 12, 2021
Completion: Apr 1, 2025
Loading map...